Ozlem Er Civelek | Baskent University (original) (raw)

Papers by Ozlem Er Civelek

Research paper thumbnail of D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer

Journal of B.U.ON.: official journal of the Balkan Union of Oncology

Purpose: D-dimer, LDH and tumor markers are usually overexpressed in colorectal carcinomas (CRC).... more Purpose: D-dimer, LDH and tumor markers are usually overexpressed in colorectal carcinomas (CRC). Our purpose was to assess the prognostic role of D-dimer, lactate dehydrogenase (LDH), CEA, CA19-9 and CA72-4 in patients with metastatic CRC treated with XELOX chemotherapy. Methods: Thirty-eight CRC patients who had evidence of distant metastasis were enrolled in the study and blood samples were taken before chemotherapy for estimation of the tumor markers CEA, CA19-9 and CA72-4, and for D-dimer and LDH. Patients were randomized into 3 groups: those with partial response (PR), stable disease (SD), and progressive disease (PD) according to their clinical and radiologic evaluation after 3 cycles of XELOX chemotherapy. All parameters were reevaluated after the 3rd cycle of chemotherapy. Results: Eighteen patients (47.3%) achieved PR, 10 (26.3%) SD, and 10 (26.3%) showed PD. After 3 cycles of XELOX CEA (20.55 vs 11.97 ng7sol;ml; p=0.002), LDH (357.50 vs 214.0 U7sol; lt; p=0.001) and D-dim...

Research paper thumbnail of Factors related to complementary/alternative medicine use among cancer patients in central Anatolia

Tumori

We aimed to evaluate the prevalence of and factors related to the use of complementary/alternativ... more We aimed to evaluate the prevalence of and factors related to the use of complementary/alternative medicine among cancer patients undergoing or following conventional treatment at the Erciyes University Oncology Hospital in Central Anatolia. Face-to-face interview and a questionnaire were carried out with cancer patients attending the outpatient clinic of Medical Oncology. Questionnaire items included patients' demographic data, treatment, use of complementary/alternative medicine and possible related factors. Multivariate analysis was performed to compare the factors related to use of complementary/alternative medicine. A total of 268 consecutive cancer patients were enrolled in the study. Overall, 43% of the patients were using or had used complementary/alternative medicine. Totally, 90% of the patients using complementary/alternative medicine utilized herbs, and most of the herbs used were stinging nettle. Nearly half of the patients using complementary/alternative medicine (...

Research paper thumbnail of Rectal carcinoid tumor with bone marrow and osteoblastic bone metastasis: a case report

The Turkish journal of gastroenterology: the official journal of Turkish Society of Gastroenterology

Rectal carcinoids comprise 12.6% of all carcinoid tumors and represent the third largest group of... more Rectal carcinoids comprise 12.6% of all carcinoid tumors and represent the third largest group of the gut carcinoids. A 64-year-old woman was diagnosed as high-grade neuroendocrine carcinoma. She had liver, bone, and bone marrow metastasis. Carcinoid syndrome was diagnosed due to diarrhea, nausea, vomiting, tachycardia, and high level of 24-hour urinary 5-hydroxyindoleacetic acid (160 mg/24 hours). No response was obtained by octreotide treatment. Rectal carcinoid tumors usually show favorable prognosis; however, poorly differentiated tumors might have unusually aggressive behavior and resistance to treatment. Bone marrow involvement might be a poor prognostic factor in carcinoid tumor as has been the case in many other tumors.

Research paper thumbnail of WHAT MAKES SMEs in NEWLY INDUSTRIALIZED COUNTRIES INNOVATE?: A CASE STUDY of A MEDIUM-SIZED MANUFACTURING COMPANY FROM TURKEY

The literature on technological change points out that incremental innovations and redesign of ex... more The literature on technological change points out that incremental innovations and redesign of existing products are economically and commercially as important as radical innovations. Indeed design input is required for every innovation from the most radical to incremental and through the effective use of design, companies can continuously introduce innovative products independently from the fact that they contain technologically new

Research paper thumbnail of A case of malignant melanoma with disseminated hemorrhagic metastases

Around 4-5% of all patients with malignancy present with metastasis of unknown origin; the group ... more Around 4-5% of all patients with malignancy present with metastasis of unknown origin; the group of patients who have hemorrhagic metastases particularly involve malignant melanoma, renal cell carcinoma and choriocarcinoma. A case of malignant melanoma with disseminated hemorrhagic metastases to the brain, ovary and both breasts was presented. The literature was reviewed in relation to clinical, radiologic, histopathologic and immunohistochemical findings.

Research paper thumbnail of The effect of small-molecular-weight heparin added to chemotherapy on survival in small-cell lung cancer - A retrospective analysis

Indian journal of cancer

Aims and Background: Small cell lung cancer (SCLC) is a chemotherapy-responsive tumor and associa... more Aims and Background: Small cell lung cancer (SCLC) is a chemotherapy-responsive tumor and associated with alterations in the coagulation system. Addition of low-molecular-weight heparin (LMWH) to combination chemotherapy (CT) had resulted in increase in survival. The present retrospective trial was designed to determine whether the duration of dalteparin usage has an effect on progression and survival. Materials and Methods: The medical records of 67 patients with SCLC who were given cisplatin-etoposide and concomitant LMWH (dalteparin) was evaluated retrospectively. Results: Median follow-up of patients was 11.3 months. Outcome: 10.6% complete response, 3.0% good partial response, 36.4% partial response, 10.6% stable disease, and 39.4% progressive disease. Side-effects were seen in 40.3% of the patients. Median dalteparin duration was 6,1 months. According the duration of dalteparin patients were grouped in three: who took dalteparin less than 4 months (Group A), 4-6 months (Group ...

Research paper thumbnail of Positive effects of oral β-glucan on mucositis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy

Asian Pacific journal of cancer prevention : APJCP, 2014

The present study aimed to determine the effect of oral β-glucan on mucositis and leukopenia in 6... more The present study aimed to determine the effect of oral β-glucan on mucositis and leukopenia in 62 consecutive patients with colorectal cancer treated with an adjuvant FOLFOX-4 regimen. The patients were retrospectively evaluated in 2 groups: one group received β-glucan and the other did not (control group). Leucocytes, neutrophils, and platelets were evaluated before and 1 week after chemotherapy and oral mucositis and diarrhea were noted. Leucocyte and neutrophil counts after chemotherapy in the β-glucan group were 7,300/mm3 and 3,800/mm3, respectively, and the reductions, as compared to baseline, were not significant (p=0.673 and 0.784). The median platelet count was 264,000/mm3 after chemotherapy in the β-glucan group and the reduction, as compared to baseline, was borderline significant (p=0.048). In the control group, reduction in leucocyte, neutrophil, and platelet counts was statistically significant. Oral mucositis and diarrhea were less common in the β-glucan group. We con...

Research paper thumbnail of ERCC1 is not expressed in hepatocellular cancer: A turkish oncology group, gastrointestinal oncology subgroup study

Journal of B.U.ON. : official journal of the Balkan Union of Oncology

hepatocellular cancer (HCC) is a common malignancy with a high mortality rate. Existence of excis... more hepatocellular cancer (HCC) is a common malignancy with a high mortality rate. Existence of excisional repair cross complementation1 (ERCC1) is implicated in resistance to cisplatin treatment. Expression of ERCC1 in HCC is not known. In this study we aimed to find out whether a subset of HCC patients can be identified to benefit from cisplatin. sixty-one patients with HCC who had enough tissue to do immunohistochemistry were identified in 3 institutions. Immunohistochemical staining was performed manually using the standard streptavidin-biotin-peroxidase method. Monoclonal anti-ERCC 1 (D-10) antibody from Santa Cruz Biotechnology (Santa Cruz, CA) was used. only one out of 61 patients (1.6%) had ERCC1 expression. although around 10% of HCC patients respond to cisplatin, this is unlikely to be due to ERCC1 negativity. Pathways other than ERCC1 should be searched to find ways to help these patients' treatment strategies.

Research paper thumbnail of Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer

Journal of the National Medical Association, 2009

The aim of the study was to evaluate the efficacy and tolerability of gemcitabine and uracil-tega... more The aim of the study was to evaluate the efficacy and tolerability of gemcitabine and uracil-tegafur (UFT) combination in patients with advanced pancreatic carcinoma, retrospectively. Thirty-one patients, including 27 with metastatic disease, were treated with gemcitabine at a dose of 1000 mg/m2 in 30 minutes on days 1 and 8, and oral UFT 300 mg/m2 on days 1-14, as the first-line regimen in advanced stage. The cycle was repeated every 21 days. A total of 116 cycles of chemotherapy were administered, with a median of 3 cycles per patient (range 1-13). The objective response rate was observed in 6 (19.3%) patients with 1 (3.2%) complete response, and 5 (16.1%) partial responses. The median response duration was 4 (range, 3-14) months. Eight (25.8%) patients had a standard deviation of more than 3 months. Median overall survival was 8 months (95% CI, 6-10 months) and median time to progression was 4.2 months (95% CI, 1-6 months). This combination was generally well tolerated. There wer...

Research paper thumbnail of Evaluation of malignant mesothelioma in central Anatolia: a study of 67 cases

Canadian respiratory journal : journal of the Canadian Thoracic Society

Malignant mesothelioma (MM) is a fatal neoplasm which frequently results from exposure to asbesto... more Malignant mesothelioma (MM) is a fatal neoplasm which frequently results from exposure to asbestos or erionite. Sixty-seven patients with MM were seen between 1990 and 2001. Their clinical and radiological features, as well as the therapy, were retrospectively evaluated. In 51 patients (76.1%), the MM was confined to the pleura, in 14 patients it was exclusively peritoneal and in two patients, it involved both areas. Of the 67 cases, 35 (52.2%) were women. The mean (+/- SD) age for all cases was 57.6+/-11.5 years. Dyspnea (67.2%), cough (55.2%) and chest pain (50.7%) were the most frequent symptoms of onset. Pleural effusion (92.4%) was the most common chest x-ray finding, whereas pleural effusion (60.8%), pleural nodules (34.7%) and pleural thickening (34.7%) were the most common computed tomography findings in pleural MM patients. The histological subtypes of MM were determined as epithelial in 60 patients (89.5%), sarcomatous in four patients (5.9%) and mixed in three patients (4...

Research paper thumbnail of Cyclooxygenase-2 expression in gastrointestinal stromal tumours

Asian Pacific journal of cancer prevention : APJCP, 2010

While it is well known that cyclooxygenase-2 (COX-2) expression is increased in colorectal adenom... more While it is well known that cyclooxygenase-2 (COX-2) expression is increased in colorectal adenoma and carcinoma, there is only limited information on its status in stromal tumours. Immunohistochemical COX-2 staining was performed on a total of 42 confirmed gastrointestinal stromal tumours (GISTs) in the Pathology Department of Gaziantep University and the findings were compared with various other parameters. We found a statistically significant correlation between the tumor mitosis and COX-2 expression in GISTs. However, there was no relationship between COX-2 expression and death rate, presence of metastasis, tumour size, risk staging, usage of tyrosine kinase inhibitors, and complete resection rate. In the light of these findings, the usage of COX-2 inhibitors with or without tyrosine kinase inhibitors in GIST patients may be helpful in the adjuvant setting to prevent or delay recurrence. Moreover, we need more studies to define the status of COX-2 inhibitors in GISTs.

Research paper thumbnail of Evaluation of expression of ERCC1 in hepatocellular cancer

e14685 Background: Hepatocellular cancer (HCC) is a common cancer, especially in Asia. The pathog... more e14685 Background: Hepatocellular cancer (HCC) is a common cancer, especially in Asia. The pathogenesis of this disease is multifactorial and includes many pathways. Excisional repair cross complem...

Research paper thumbnail of Correspondence

Research paper thumbnail of Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer

Research paper thumbnail of Rapidly Relapsing Squamous Cell Carcinoma of the Renal Pelvis Associated with Paraneoplastic Syndromes of Leukocytosis, Thrombocytosis and Hypercalcemia

Urologia Internationalis, 2001

A case history is reported here in which leukocytosis, thrombocytosis and hypercalcemia associate... more A case history is reported here in which leukocytosis, thrombocytosis and hypercalcemia associated with rapidly relapsing squamous cell carcinoma (SCC) of the renal pelvis were observed. In a 58-year-old man, SCC of the renal pelvis was documented during nephrolithotomy, and right nephrectomy was performed. Local relapse of the tumor occurred rapidly in 2 months' time and hypercalcemia, leukocytosis and thrombocytosis worsened in accordance with tumor volume. Cranial computerized tomography (CT), thorax CT and bone scintigraphy were negative for metastasis. The serum parathyroid hormone level was 28 pg/ml (normal 9- 55 pg/ml). To disclose leukocytosis and thrombocytosis, peripheral smear and bone marrow aspiration were performed and no pathologic finding regarding any hematologic disorder was found; the samples were also BCR-ABL negative and Philadelphia chromosome negative. Production of several factors by tumor cells may be responsible for this paraneoplastic syndrome. The association of SCC of the renal pelvis with this triple paraneoplastic syndrome is an extremely rare occurrence.

Research paper thumbnail of Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin

Research paper thumbnail of Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer

Research paper thumbnail of Ifosfamide, Mesna, and Interferon-Alpha2A Combination Chemoimmunotherapy in Malignant Mesothelioma: Results of a Single Center in Central Anatolia

Research paper thumbnail of Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature

Medical Oncology, 2009

Sunitinib is a novel oral multitargeted tyrosine kinase inhibitor. It has higher response rates a... more Sunitinib is a novel oral multitargeted tyrosine kinase inhibitor. It has higher response rates and progression-free survival in patients with metastatic renal cell carcinoma (RCC) when compared with standard chemotherapy and interferon-alpha. We report a case of paraneoplastic hypercalcemia, resistant to conventional treatment but recovers by sunitinib treatment as the first case in the literature, in a 33-years-old man with metastatic RCC. At the sixth month of follow-up period, in this case, serum calcium level was still in normal ranges. Besides sunitinib is effective in symptom control, it is also helpful in management of paraneoplastic hypercalcemia, a life-threatening entity.

Research paper thumbnail of Irinotecan plus Cisplatin Combination Against Metastatic Gastric Cancer: Phase II Study

Research paper thumbnail of D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer

Journal of B.U.ON.: official journal of the Balkan Union of Oncology

Purpose: D-dimer, LDH and tumor markers are usually overexpressed in colorectal carcinomas (CRC).... more Purpose: D-dimer, LDH and tumor markers are usually overexpressed in colorectal carcinomas (CRC). Our purpose was to assess the prognostic role of D-dimer, lactate dehydrogenase (LDH), CEA, CA19-9 and CA72-4 in patients with metastatic CRC treated with XELOX chemotherapy. Methods: Thirty-eight CRC patients who had evidence of distant metastasis were enrolled in the study and blood samples were taken before chemotherapy for estimation of the tumor markers CEA, CA19-9 and CA72-4, and for D-dimer and LDH. Patients were randomized into 3 groups: those with partial response (PR), stable disease (SD), and progressive disease (PD) according to their clinical and radiologic evaluation after 3 cycles of XELOX chemotherapy. All parameters were reevaluated after the 3rd cycle of chemotherapy. Results: Eighteen patients (47.3%) achieved PR, 10 (26.3%) SD, and 10 (26.3%) showed PD. After 3 cycles of XELOX CEA (20.55 vs 11.97 ng7sol;ml; p=0.002), LDH (357.50 vs 214.0 U7sol; lt; p=0.001) and D-dim...

Research paper thumbnail of Factors related to complementary/alternative medicine use among cancer patients in central Anatolia

Tumori

We aimed to evaluate the prevalence of and factors related to the use of complementary/alternativ... more We aimed to evaluate the prevalence of and factors related to the use of complementary/alternative medicine among cancer patients undergoing or following conventional treatment at the Erciyes University Oncology Hospital in Central Anatolia. Face-to-face interview and a questionnaire were carried out with cancer patients attending the outpatient clinic of Medical Oncology. Questionnaire items included patients' demographic data, treatment, use of complementary/alternative medicine and possible related factors. Multivariate analysis was performed to compare the factors related to use of complementary/alternative medicine. A total of 268 consecutive cancer patients were enrolled in the study. Overall, 43% of the patients were using or had used complementary/alternative medicine. Totally, 90% of the patients using complementary/alternative medicine utilized herbs, and most of the herbs used were stinging nettle. Nearly half of the patients using complementary/alternative medicine (...

Research paper thumbnail of Rectal carcinoid tumor with bone marrow and osteoblastic bone metastasis: a case report

The Turkish journal of gastroenterology: the official journal of Turkish Society of Gastroenterology

Rectal carcinoids comprise 12.6% of all carcinoid tumors and represent the third largest group of... more Rectal carcinoids comprise 12.6% of all carcinoid tumors and represent the third largest group of the gut carcinoids. A 64-year-old woman was diagnosed as high-grade neuroendocrine carcinoma. She had liver, bone, and bone marrow metastasis. Carcinoid syndrome was diagnosed due to diarrhea, nausea, vomiting, tachycardia, and high level of 24-hour urinary 5-hydroxyindoleacetic acid (160 mg/24 hours). No response was obtained by octreotide treatment. Rectal carcinoid tumors usually show favorable prognosis; however, poorly differentiated tumors might have unusually aggressive behavior and resistance to treatment. Bone marrow involvement might be a poor prognostic factor in carcinoid tumor as has been the case in many other tumors.

Research paper thumbnail of WHAT MAKES SMEs in NEWLY INDUSTRIALIZED COUNTRIES INNOVATE?: A CASE STUDY of A MEDIUM-SIZED MANUFACTURING COMPANY FROM TURKEY

The literature on technological change points out that incremental innovations and redesign of ex... more The literature on technological change points out that incremental innovations and redesign of existing products are economically and commercially as important as radical innovations. Indeed design input is required for every innovation from the most radical to incremental and through the effective use of design, companies can continuously introduce innovative products independently from the fact that they contain technologically new

Research paper thumbnail of A case of malignant melanoma with disseminated hemorrhagic metastases

Around 4-5% of all patients with malignancy present with metastasis of unknown origin; the group ... more Around 4-5% of all patients with malignancy present with metastasis of unknown origin; the group of patients who have hemorrhagic metastases particularly involve malignant melanoma, renal cell carcinoma and choriocarcinoma. A case of malignant melanoma with disseminated hemorrhagic metastases to the brain, ovary and both breasts was presented. The literature was reviewed in relation to clinical, radiologic, histopathologic and immunohistochemical findings.

Research paper thumbnail of The effect of small-molecular-weight heparin added to chemotherapy on survival in small-cell lung cancer - A retrospective analysis

Indian journal of cancer

Aims and Background: Small cell lung cancer (SCLC) is a chemotherapy-responsive tumor and associa... more Aims and Background: Small cell lung cancer (SCLC) is a chemotherapy-responsive tumor and associated with alterations in the coagulation system. Addition of low-molecular-weight heparin (LMWH) to combination chemotherapy (CT) had resulted in increase in survival. The present retrospective trial was designed to determine whether the duration of dalteparin usage has an effect on progression and survival. Materials and Methods: The medical records of 67 patients with SCLC who were given cisplatin-etoposide and concomitant LMWH (dalteparin) was evaluated retrospectively. Results: Median follow-up of patients was 11.3 months. Outcome: 10.6% complete response, 3.0% good partial response, 36.4% partial response, 10.6% stable disease, and 39.4% progressive disease. Side-effects were seen in 40.3% of the patients. Median dalteparin duration was 6,1 months. According the duration of dalteparin patients were grouped in three: who took dalteparin less than 4 months (Group A), 4-6 months (Group ...

Research paper thumbnail of Positive effects of oral β-glucan on mucositis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy

Asian Pacific journal of cancer prevention : APJCP, 2014

The present study aimed to determine the effect of oral β-glucan on mucositis and leukopenia in 6... more The present study aimed to determine the effect of oral β-glucan on mucositis and leukopenia in 62 consecutive patients with colorectal cancer treated with an adjuvant FOLFOX-4 regimen. The patients were retrospectively evaluated in 2 groups: one group received β-glucan and the other did not (control group). Leucocytes, neutrophils, and platelets were evaluated before and 1 week after chemotherapy and oral mucositis and diarrhea were noted. Leucocyte and neutrophil counts after chemotherapy in the β-glucan group were 7,300/mm3 and 3,800/mm3, respectively, and the reductions, as compared to baseline, were not significant (p=0.673 and 0.784). The median platelet count was 264,000/mm3 after chemotherapy in the β-glucan group and the reduction, as compared to baseline, was borderline significant (p=0.048). In the control group, reduction in leucocyte, neutrophil, and platelet counts was statistically significant. Oral mucositis and diarrhea were less common in the β-glucan group. We con...

Research paper thumbnail of ERCC1 is not expressed in hepatocellular cancer: A turkish oncology group, gastrointestinal oncology subgroup study

Journal of B.U.ON. : official journal of the Balkan Union of Oncology

hepatocellular cancer (HCC) is a common malignancy with a high mortality rate. Existence of excis... more hepatocellular cancer (HCC) is a common malignancy with a high mortality rate. Existence of excisional repair cross complementation1 (ERCC1) is implicated in resistance to cisplatin treatment. Expression of ERCC1 in HCC is not known. In this study we aimed to find out whether a subset of HCC patients can be identified to benefit from cisplatin. sixty-one patients with HCC who had enough tissue to do immunohistochemistry were identified in 3 institutions. Immunohistochemical staining was performed manually using the standard streptavidin-biotin-peroxidase method. Monoclonal anti-ERCC 1 (D-10) antibody from Santa Cruz Biotechnology (Santa Cruz, CA) was used. only one out of 61 patients (1.6%) had ERCC1 expression. although around 10% of HCC patients respond to cisplatin, this is unlikely to be due to ERCC1 negativity. Pathways other than ERCC1 should be searched to find ways to help these patients' treatment strategies.

Research paper thumbnail of Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer

Journal of the National Medical Association, 2009

The aim of the study was to evaluate the efficacy and tolerability of gemcitabine and uracil-tega... more The aim of the study was to evaluate the efficacy and tolerability of gemcitabine and uracil-tegafur (UFT) combination in patients with advanced pancreatic carcinoma, retrospectively. Thirty-one patients, including 27 with metastatic disease, were treated with gemcitabine at a dose of 1000 mg/m2 in 30 minutes on days 1 and 8, and oral UFT 300 mg/m2 on days 1-14, as the first-line regimen in advanced stage. The cycle was repeated every 21 days. A total of 116 cycles of chemotherapy were administered, with a median of 3 cycles per patient (range 1-13). The objective response rate was observed in 6 (19.3%) patients with 1 (3.2%) complete response, and 5 (16.1%) partial responses. The median response duration was 4 (range, 3-14) months. Eight (25.8%) patients had a standard deviation of more than 3 months. Median overall survival was 8 months (95% CI, 6-10 months) and median time to progression was 4.2 months (95% CI, 1-6 months). This combination was generally well tolerated. There wer...

Research paper thumbnail of Evaluation of malignant mesothelioma in central Anatolia: a study of 67 cases

Canadian respiratory journal : journal of the Canadian Thoracic Society

Malignant mesothelioma (MM) is a fatal neoplasm which frequently results from exposure to asbesto... more Malignant mesothelioma (MM) is a fatal neoplasm which frequently results from exposure to asbestos or erionite. Sixty-seven patients with MM were seen between 1990 and 2001. Their clinical and radiological features, as well as the therapy, were retrospectively evaluated. In 51 patients (76.1%), the MM was confined to the pleura, in 14 patients it was exclusively peritoneal and in two patients, it involved both areas. Of the 67 cases, 35 (52.2%) were women. The mean (+/- SD) age for all cases was 57.6+/-11.5 years. Dyspnea (67.2%), cough (55.2%) and chest pain (50.7%) were the most frequent symptoms of onset. Pleural effusion (92.4%) was the most common chest x-ray finding, whereas pleural effusion (60.8%), pleural nodules (34.7%) and pleural thickening (34.7%) were the most common computed tomography findings in pleural MM patients. The histological subtypes of MM were determined as epithelial in 60 patients (89.5%), sarcomatous in four patients (5.9%) and mixed in three patients (4...

Research paper thumbnail of Cyclooxygenase-2 expression in gastrointestinal stromal tumours

Asian Pacific journal of cancer prevention : APJCP, 2010

While it is well known that cyclooxygenase-2 (COX-2) expression is increased in colorectal adenom... more While it is well known that cyclooxygenase-2 (COX-2) expression is increased in colorectal adenoma and carcinoma, there is only limited information on its status in stromal tumours. Immunohistochemical COX-2 staining was performed on a total of 42 confirmed gastrointestinal stromal tumours (GISTs) in the Pathology Department of Gaziantep University and the findings were compared with various other parameters. We found a statistically significant correlation between the tumor mitosis and COX-2 expression in GISTs. However, there was no relationship between COX-2 expression and death rate, presence of metastasis, tumour size, risk staging, usage of tyrosine kinase inhibitors, and complete resection rate. In the light of these findings, the usage of COX-2 inhibitors with or without tyrosine kinase inhibitors in GIST patients may be helpful in the adjuvant setting to prevent or delay recurrence. Moreover, we need more studies to define the status of COX-2 inhibitors in GISTs.

Research paper thumbnail of Evaluation of expression of ERCC1 in hepatocellular cancer

e14685 Background: Hepatocellular cancer (HCC) is a common cancer, especially in Asia. The pathog... more e14685 Background: Hepatocellular cancer (HCC) is a common cancer, especially in Asia. The pathogenesis of this disease is multifactorial and includes many pathways. Excisional repair cross complem...

Research paper thumbnail of Correspondence

Research paper thumbnail of Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer

Research paper thumbnail of Rapidly Relapsing Squamous Cell Carcinoma of the Renal Pelvis Associated with Paraneoplastic Syndromes of Leukocytosis, Thrombocytosis and Hypercalcemia

Urologia Internationalis, 2001

A case history is reported here in which leukocytosis, thrombocytosis and hypercalcemia associate... more A case history is reported here in which leukocytosis, thrombocytosis and hypercalcemia associated with rapidly relapsing squamous cell carcinoma (SCC) of the renal pelvis were observed. In a 58-year-old man, SCC of the renal pelvis was documented during nephrolithotomy, and right nephrectomy was performed. Local relapse of the tumor occurred rapidly in 2 months' time and hypercalcemia, leukocytosis and thrombocytosis worsened in accordance with tumor volume. Cranial computerized tomography (CT), thorax CT and bone scintigraphy were negative for metastasis. The serum parathyroid hormone level was 28 pg/ml (normal 9- 55 pg/ml). To disclose leukocytosis and thrombocytosis, peripheral smear and bone marrow aspiration were performed and no pathologic finding regarding any hematologic disorder was found; the samples were also BCR-ABL negative and Philadelphia chromosome negative. Production of several factors by tumor cells may be responsible for this paraneoplastic syndrome. The association of SCC of the renal pelvis with this triple paraneoplastic syndrome is an extremely rare occurrence.

Research paper thumbnail of Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin

Research paper thumbnail of Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer

Research paper thumbnail of Ifosfamide, Mesna, and Interferon-Alpha2A Combination Chemoimmunotherapy in Malignant Mesothelioma: Results of a Single Center in Central Anatolia

Research paper thumbnail of Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature

Medical Oncology, 2009

Sunitinib is a novel oral multitargeted tyrosine kinase inhibitor. It has higher response rates a... more Sunitinib is a novel oral multitargeted tyrosine kinase inhibitor. It has higher response rates and progression-free survival in patients with metastatic renal cell carcinoma (RCC) when compared with standard chemotherapy and interferon-alpha. We report a case of paraneoplastic hypercalcemia, resistant to conventional treatment but recovers by sunitinib treatment as the first case in the literature, in a 33-years-old man with metastatic RCC. At the sixth month of follow-up period, in this case, serum calcium level was still in normal ranges. Besides sunitinib is effective in symptom control, it is also helpful in management of paraneoplastic hypercalcemia, a life-threatening entity.

Research paper thumbnail of Irinotecan plus Cisplatin Combination Against Metastatic Gastric Cancer: Phase II Study